The Effectiveness of Digital Intervention on Psychological Resilience in Postoperative Breast Cancer Patients During Chemotherapy Intervals: Quasi-Experimental Study - Summary - MDSpire
To evaluate the impact of digital interventions on psychological resilience among breast cancer patients during chemotherapy recovery.
Approach:
Study Design: A quasi-experimental analysis was conducted to assess the effectiveness of digital mindfulness-based cancer recovery interventions.
Intervention: The study involved a 4-week online mindfulness-based cancer recovery program that included mindfulness meditation, body scan, and mindful breathing exercises.
Key Findings:
Digital interventions improved psychological resilience among breast cancer patients.
Participants reported reduced anxiety and depressive symptoms.
The online format allowed for greater accessibility and reduced risks associated with in-person interventions.
Interpretation:
The findings suggest that digital mindfulness interventions can be effective in enhancing psychological resilience and reducing psychological distress in breast cancer patients during chemotherapy recovery.
Limitations:
Previous studies did not specifically target postoperative breast cancer patients during chemotherapy intervals.
Existing digital mindfulness interventions may not adequately address unique challenges faced by this population, such as functional limitations.
Conclusion:
Digital mindfulness interventions represent a promising approach to support psychological resilience in breast cancer patients during recovery from chemotherapy.
Patients with estrogen-receptor-positive (ER+) HER-2-negative advanced breast cancer experienced significantly improved progression-free survival (PFS) when treated with an oral combination regimen that included giredestrant, a novel, next-generation selective ER degrader and full antagonist (SERD), compared to a standard combination approach.
Researchers develop targeted lipoplex platform that generates CAR T and NK cells directly within tumors, improving survival in preclinical breast cancer models
